GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Predictive Technology Group PREDQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2020

Revenue

$24.4m

FY2016FY2020

Net income

−$85.8m

FY2016FY2020

Free cash flow

−$14.1m

FY2016FY2020

Shareholders' equity

$55.3m

FY2016FY2020

Income statement

Fiscal years

FY2020FY2019FY2018FY2017FY2016
Revenue$24.4m$43.5m$16.6m$2.6m$75,300
Research and development$6.0m$5.8m$1.9m$84,700$1,000
Operating income−$46.7m−$19.9m−$12.3m−$4.8m−$2.4m
Net income−$85.8m−$15.3m−$13.0m−$6.2m−$16.6m
Diluted earnings per share-0.30-0.06-0.06-0.03-0.10

Balance sheet

At each fiscal year end

FY2020FY2019FY2018FY2017FY2016
Total assets$83.8m$143.6m$104.0m$42.9m$39.9m
Cash and short-term investments$331,200$1.6m$1.2m$968,200$4,500
Total liabilities$28.6m$30.8m$22.5m$1.1m$74,800
Debt$6.7m$2.4m———
Shareholders' equity$55.3m$112.8m$81.5m$41.8m$39.9m
Shares outstanding290m266m218m202m164m

Cash flow

Fiscal years

FY2020FY2019FY2018FY2017FY2016
Cash from operations−$13.1m$3.5m−$289,000$918,100−$141,400
Capital spending−$1.0m−$2.7m−$1.9m−$2.1m−$325,200
Free cash flow−$14.1m$786,300−$2.2m−$1.1m−$466,600

Latest quarters

By quarter end

Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020Dec 2019Sept 2019Jun 2019
Revenue$6.9m$4.1m$5.1m$3.1m$5.7m$7.3m$8.3m$13.4m
Operating income−$3.2m−$6.9m−$7.5m−$8.3m−$11.7m−$13.7m−$12.9m−$10.1m
Net income−$7.4m−$7.1m−$15.5m−$38.2m−$13.7m−$26.0m−$7.9m−$7.3m
Diluted earnings per share-0.02-0.02-0.05-0.14-0.05-0.09-0.03-0.03
Total assets$67.0m$70.5m$74.4m$83.8m$114.0m$119.2m$140.0m$143.6m
Cash and short-term investments$152,000$134,400$1.3m$331,200$206,400$255,500$841,800$1.6m
Debt$3.3m$2.7m$7.5m$5.3m$3.8m$11.3m$7.8m$1.9m
Shareholders' equity$32.3m$38.3m$42.8m$55.3m$91.2m$88.5m$109.9m$112.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue111.4%——
Operating income113.6%338.8%—
Net income140.4%395.2%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-98.0%-96.1%——
Net margin-148.8%-137.9%——

Valuation history

At each fiscal year end

FY2016
Price to sales0.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-90%4567%900%-72%-65%-88%73%5%-53%29%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 29 Jul 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.